Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Horny HP . Mastocytosis: an unusual clonal disorder of bone marrow-derived hematopoietic progenitor cells. Am J Clin Pathol 2009; 132: 438–447.

    Article  Google Scholar 

  2. Agis H, Sotlar K, Valent P, Horny HP . Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis. Leuk Res 2005; 29: 1227–1232.

    Article  CAS  Google Scholar 

  3. Horny HP, Sotlar K, Stellmacher F, Krokowski M, Agis H, Schwartz LB et al. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers. J Clin Pathol 2006; 59: 298–302.

    Article  Google Scholar 

  4. Hussein K, Bock O, Theophile K, Seegers A, Arps H, Basten O et al. Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation. Leukemia 2008; 22: 1059–1062.

    Article  CAS  Google Scholar 

  5. Buesche G, Ganser A, Schlegelberger B, von Neuhoff N, Gadzicki D, Hecker H et al. Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia. Leukemia 2007; 21: 2420–2427.

    Article  CAS  Google Scholar 

  6. Sotlar K, Bache A, Stellmacher F, Bültmann B, Valent P, Horny HP . Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a clonal hematological non-mast cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. J Mol Diagn 2008; 10: 58–66.

    Article  CAS  Google Scholar 

  7. Michor F . Mathematical models of cancer stem cells. J Clin Oncol 2008; 26: 2854–2861.

    Article  Google Scholar 

  8. Abruzzese E, Gozzetti A, Galimberti S, Trawinska MM, Caravita T, Siniscalchi A et al. Characterization of Ph-negative abnormal clones emerging during imatinib therapy. Cancer 2007; 109: 2466–2472.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We wish to thank Sabine Schröter, Nadine Preiß and Markus Meyer for their skillful work in the laboratory. Furthermore, we are grateful to Dr Philipp Ahrens for his sophisticated assistance of FFPE–FISH evaluation. Research grants: José Carreras Leukämie-Stiftung SP10/06 (KH).

Author contribution

Histopathology (KH, H-PH, GB, HK), molecular pathology (KH, OB), cytogenetic analysis (GG), FFPE-FISH (KH, GG), clinical data (MG), study design and manuscript preparation (KH, H-PH, GB, MG, GG, HK, OB).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Hussein.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hussein, K., Horny, HP., Büsche, G. et al. Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone. Leukemia 25, 1050–1053 (2011). https://doi.org/10.1038/leu.2011.41

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2011.41

This article is cited by

Search

Quick links